Replication study of polymorphisms associated with brain arteriovenous malformation in a population from South of Brazil

• Autor(a) principal: Franciscatto, Andre Cerutti
• Data de Publicação: 2016
• Outros Autores: Sperb, Fernanda, Matte, Ursula da Silveira, Mota, Simone Sieben da, Stefani, Marco Antonio
• Tipo de documento: Artigo
• Idioma: eng
• Título da fonte: Repositório Institucional da UFRGS
• Texto Completo: http://hdl.handle.net/10183/271008
• topic: Malformações arteriovenosas intracranianas; Polimorfismo de nucleotídeo único; Apolipoproteínas E; Endoglina; Fator de necrose tumoral alfa; Interleucina-1beta; Interleucina-6; Brasil, Região Sul; Brain arteriovenous malformation; Single nucleotide polymorphisms; Apolipoprotein e; Activine-like kinase 1; Endoglin; Tumor necrosis factor alpha

Introduction: The aim of this study was to reproducibly determine if any of the polymorphisms were associated with the susceptibility to brain arteriovenous malformations (BAVM) or the risk of intracranial hemorrhage (ICH) presentation. Methods: We recruited 63 BAVM patients and 96 controls. The polymorphisms selected for evaluation were apolipoprotein E (APOE), tumor necrosis factor alpha (TNF 238G>A - rs361525), interleukin 1 beta (IL1B 511C>T - rs16944 and IL1B -31T>C - rs1143627), activin-like kinase 1 (ACVRL1 IVS3-35A>G - rs2071219), endoglin (ENG 207G>A - rs11545664), and interleukin 6 (IL6 174G>C - rs1800795). Results: In the single analysis, we observed statistically significant differences in the allele distributions for IL1B - 31T>C (rs1143627) between the BAVM patients and control subjects (P = 0.02). There was a trend toward significance for the association between the IL1B 511C>T (rs16944) allele and BAVM risk (P = 0.07). In further logistic regression analysis, no polymorphism was significantly associated with the risk of BAVM. No polymorphisms were associated with hemorrhage presentation according to both single and multivariable analyses. Conclusions: In our sample from a south Brazil population, we found no association between the risks of BAVM and ICH presentation with any of the selected polymorphisms.